Cookies help us to understand you better. Browse on or click to

Training and Support Contact Us
Our Websites
ZA
AR
AT
AU
BE
CA
CH
CL
CN
CO
DE
DK
ES
FI
FR
GR
IL
IN
IT
JP
KR
LU
MY
MX
NL
NO
NZ
PH
RU
SE
SG
TR
TW
US
ZA
Product Login
Lexis® Library
Lexis® Sign
Lexis® MetroIQ
Lexis® Diligence
Lexis® Practical Guidance
Lexis® RefCheck
Lexis® RatesClearance
Lexis® Assure
Lexis® Procurecheck
Lexis® Convey
Lexis® WinDeed
Lexis® AgentIQ
Lexis® PropIQ
Lexis® SACompany
Image Lexis Nexis
Menu
  • Products and Services
    • < Products and Services
    • Product Category
      • < Product Category
      • Research and Guidance
      • Governance, Risk and Compliance
      • Data Services
      • Business Software Solutions
      • Academic
      • Product Training
      • Product Training Webinars
      • eLearning
    • Interest Area
      • < Interest Area
      • Civil Procedure
      • Case Law
      • Financial Services
      • Labour and Employment
      • Legislation
      • Tax
    • Product Index
      • < Product Index
      • Lexis® Library
      • Lexis® RefCheck
      • Lexis® Convey
      • Lexis® WinDeed
      • Lexis® ProcureCheck
      • Lexis® Practical Guidance
      • Lexis® Sign
      • Lexis® Assure
      • Lexis® RatesClearance
      • Lexis® MetroIQ
      See All Products
  • ROL Information Centre
    • < ROL Information Centre
    • Resources
      • < Resources
      • COVID-19 Resource Centre
      • GBV Resource Centre
      • Rebuilding South Africa
      • Severe Weather Events Resource Centre
  • Blogs
    • < Blogs
    • By Blog Title
      • < By Blog Title
      • Legal
      • Corporate
      • Government
      • Conveyancing
      • Resources
      • Latest Cases
      • Other News
      See All Blogs
    • Webinars
      • < Webinars
      Webinars
  • About Us
    • < About Us
    • About LexisNexis
      • < About LexisNexis
      • Overview
      • Careers
      • Leadership Team
      • Company Information
      • Corporate Responsibility
      • Diversity and Inclusion
      • The Rule of Law
    • Useful Links
      • < Useful Links
      • News and Insights
      • LexisNexis Africa
      • Product Index
      • Store
      • BEE
  • Store
    • < Store
    • Law
      • < Law
      • Advertising Law
      • Aviation Law
      • B-BBEE
      • Civil Procedure
      • Legal Practice
      • Local Government
      • Safety and Security
      • Current Service Issue Schedule
      See All Subject Areas
    • Tax
      • < Tax
      • Capital Gains Tax
      • Employee Tax
      • Income Tax
      • International Tax
      • Tax Administration
      • Tax Legislation
      • VAT
      • Current Service Issue Schedule
      See All Subject Areas
    • Financial Services
      • < Financial Services
      • Banking and Finance
      • Employee Benefits/Pension
      • Financial Services Regulations
      • Financial Planning and Investments
      • Wills/Trusts/Estates
      • Current Service Issue Schedule
      See All Subject Areas
    • Academic
      • < Academic
      • Accounting Academic
      • Law Academic
      • Tax Academic
      See All Subject Areas
  • Contact us
    • < Contact us
Contact Us
Training and Support
  • Home
  • Lexis Digest
  • ROL Centre of Information
  • COVID-19 Resource Centre
  • Categories
  • Notices, Directives and Regulations - COVID-19
  • Directives and Media Statements - COVID-19
  • Pharmaceutical & Health
Print

Pharmaceutical & Health

  • Final Statement of Meeting with Unions (23 August 2020)
  • Health Worker Safety is of Paramount Importance to Department of Health (21 August 2020)
  • All Hands on Deck as Department of Health Recruits Nearly 2400 Interns in 2020 (21 August 2020)
  • Reduction in the Isolation Period for Patients with Confirmed COVID-19 Infection (17 July 2020)
  • Follow up Statement on Dexamethasone by the Minister of Health (19 June 2020)
  • Minister Zwelini Mkhize Notes to Media Eastern Cape Coronavirus Response (7 June 2020)
  • Minister of Health Media Statement (24 March 2020)
  • COVID-19 Joint Statement for Community Pharmacies (24 March 2020)
  • Department of Health Notice - Request to Use Chloroquine Rationally (25 March 2020)
  • Department of Health Notice - Rational Medicine Use During COVID-19 Pandemic (25 March 2020)
  • NICD - Clinical Management of Suspected or Confirmed COVID-19 Disease -Version 3 (27 March 2020)

Connect with us:

  • Facebook
  • Youtube
  • Linkedin
  • Twitter

About us

  • Overview
  • Careers
  • Leadership Team
  • Corporate Responsibility
  • The Rule of Law

Useful Links

  • News and Insights
  • LexisNexis Africa
  • Product Index
  • Store
  • BEE

Top Products

  • Lexis® WinDeed
  • Lexis® Assure
  • Lexis® Convey
  • Lexis® Diligence
  • Lexis® Library
  • Lexis® Practical Guidance

Contact Us

  • +27 (0) 860 765 432
  • customercare@lexisnexis.co.za
Lexis Nexis
  • Site Map
  • Privacy Policy
  • PAIA Manual
  • Processing Notice
  • Cookie Policy
  • Terms & Conditions
  • Copyright
  • Credit Policy

Copyright © 2022 LexisNexis. All rights reserved.

RELX Group and the RE symbol are trade marks of RELX Intellectual Properties SA, used under license.